Company Performance - QuidelOrtho reported quarterly earnings of $0.74 per share, exceeding the Zacks Consensus Estimate of $0.58 per share, and up from $0.44 per share a year ago, representing an earnings surprise of 27.59% [1] - The company posted revenues of $692.8 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.30%, although this is a decrease from year-ago revenues of $711 million [2] - Over the last four quarters, QuidelOrtho has consistently surpassed consensus EPS estimates and revenue estimates [2] Stock Performance - QuidelOrtho shares have declined approximately 41.8% since the beginning of the year, in contrast to the S&P 500's decline of 4.7% [3] - The current Zacks Rank for QuidelOrtho is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $621.72 million, and for the current fiscal year, it is $2.31 on revenues of $2.7 billion [7] - The outlook for the Medical - Products industry, to which QuidelOrtho belongs, is currently in the bottom 28% of over 250 Zacks industries, which may impact the stock's performance [8]
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates